| Susan Sherman, MD | |
|
2615 Edwards St, Alton, IL 62002-3915 | |
| (618) 462-2331 | |
| (618) 462-7160 |
| Full Name | Susan Sherman |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 2615 Edwards St, Alton, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821158288 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 036116638 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Susan Sherman, MD 2615 Edwards St, Alton, IL 62002-3915 Ph: (618) 462-2331 | Susan Sherman, MD 2615 Edwards St, Alton, IL 62002-3915 Ph: (618) 462-2331 |
News Archive
A human stem cell line derived from embryos that were identified by preimplantation genetic diagnosis (PGD) to carry the mutation for fragile X syndrome has provided an unprecedented view of early events associated with this disease.
Patients diagnosed at high-volume centers are up to 40 percent more likely to receive treatment for glioblastoma, according to a study from researchers at the University of Illinois at Chicago.
Stem Cell Theranostics announced today that they have successfully completed a research collaboration with Thermo Fisher Scientific focused on advancing the development of cardiac disease models derived from induced pluripotent stem cells using Thermo Fisher Scientific's suite of work flow reagents and SCT's patient biobank and proprietary disease modeling methods.
Stem-cell research—and its political, legal, and ethical implications—is the theme of this week's issue of THE LANCET. An editorial comments how scientists need to step forward and engage the public to make the case for the future benefits of stem-cell research.
InNexus Biotechnology Inc., a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company and the National Cancer Institute (NCI), part of the U.S. National Institutes of Health (NIH), have amended the Collaborative Agreement announced on May 27, 2010, involving research on technologies developed by InNexus.
› Verified 7 days ago
David Montani, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4500 College Ave, Alton, IL 62002 Phone: 618-474-3227 | |
Mirza S A Baig, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-2504 | |
Rupa Maitra, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4500 College Ave, Alton, IL 62002 Phone: 618-474-3800 | |
Ajitesh Rai, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4 Memorial Dr Ste 230, Alton, IL 62002 Phone: 618-465-8666 Fax: 618-465-8670 | |
Mohammad Sajed, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4 Memorial Dr Ste 230, Alton, IL 62002 Phone: 618-465-8666 Fax: 618-483-7216 | |
Jagannath Patil, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4 Memorial Dr Ste 210, Alton, IL 62002 Phone: 618-465-8829 Fax: 618-465-5599 | |
Sanghee Kim-ansbro, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4500 College Ave, Alton, IL 62002 Phone: 618-474-3800 |